CFI-401870

CAT: 0804-HY-116190Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-116190Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CFI-401870 is an orally active threonine tyrosine kinase (TTK (Mps1) ) inhibitor with an IC50 of 3.1 nM. CFI-401870 exhibits IC50s against PLK4, KDR, AURKA and other kinases such as AURKB/INCENP were all greater than 1 μM.CFI-401870 inhibits the growth of various cancer cells, causing chromosome lag, an increase in aneuploidy and cell cycle arrest. CFI-401870 can be used for the study of cancers such as colon cancer[1].
CAS Number
[1430741-35-7]
UNSPSC
12352005
Target
DNA/RNA Synthesis; Mps1
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O[C@@H]1C[C@H](CC[C@@H]2C1)N2C3=CC=C(C=C3)C4=NNC5=C4C=C(C=C5)C(N[C@H](C6CC6)C7=NC=CC=C7)=O
Molecular Formula
C30H31N5O2
Molecular Weight
493.60
References & Citations
[1]Liu Y, et al. The Discovery of Orally Bioavailable Tyrosine Threonine Kinase (TTK) Inhibitors: 3- (4- (heterocyclyl) phenyl) -1H-indazole-5-carboxamides as Anticancer Agents. J Med Chem. 2015 Apr 23;58 (8) :3366-92.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-120032CFI-401980
HY-120279ACFI-400437
HY-123675CFI-400936
HY-P88426CFI Antibody (YA8110, Mouse)
HY-132135-01(1E) -CFI-400437 (dihydrochloride)
HY-RS20677Cfi Mouse Pre-designed siRNA Set A
HY-RS02567CFI Human Pre-designed siRNA Set A
HY-RS27188Cfi Rat Pre-designed siRNA Set A
HY-124099SCH 40120
HY-18053-01AZD 4017

Alternative Products

CatalogName
MBS5780429CFI-401870
521453-01CFI
EMk27563Monkey CFI (CFI) ELISA Kit
MBS3846783-01CFI-400945
M27538-01CFI-402257
MBS9403331-01CFI Antibody
GW2058-1mgCFI-400437
32-13754-10CFI Human
MBS5780430CFI-401980
MF-0145236-01CFI-400936

Popular Products